Cargando…

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor

Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Jianglian, Gu, Tanwei, Pang, Xiaoyan, Liu, Yonghong, Tang, Lan, Zhou, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766425/
https://www.ncbi.nlm.nih.gov/pubmed/35069197
http://dx.doi.org/10.3389/fphar.2021.772435
_version_ 1784634527820283904
author She, Jianglian
Gu, Tanwei
Pang, Xiaoyan
Liu, Yonghong
Tang, Lan
Zhou, Xuefeng
author_facet She, Jianglian
Gu, Tanwei
Pang, Xiaoyan
Liu, Yonghong
Tang, Lan
Zhou, Xuefeng
author_sort She, Jianglian
collection PubMed
description Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndrome-related diseases. In recent years, natural products targeting LXRs and FXR have received remarkable interests as a valuable source of novel ligands encompassing diverse chemical structures and bioactive properties. This review aims to survey natural products, originating from terrestrial plants and microorganisms, marine organisms, and marine-derived microorganisms, which could influence LXRs and FXR. In the recent two decades (2000–2020), 261 natural products were discovered from natural resources such as LXRs/FXR modulators, 109 agonists and 38 antagonists targeting LXRs, and 72 agonists and 55 antagonists targeting FXR. The docking evaluation of desired natural products targeted LXRs/FXR is finally discussed. This comprehensive overview will provide a reference for future study of novel LXRs and FXR agonists and antagonists to target human diseases, and attract an increasing number of professional scholars majoring in pharmacy and biology with more in-depth discussion.
format Online
Article
Text
id pubmed-8766425
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87664252022-01-20 Natural Products Targeting Liver X Receptors or Farnesoid X Receptor She, Jianglian Gu, Tanwei Pang, Xiaoyan Liu, Yonghong Tang, Lan Zhou, Xuefeng Front Pharmacol Pharmacology Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndrome-related diseases. In recent years, natural products targeting LXRs and FXR have received remarkable interests as a valuable source of novel ligands encompassing diverse chemical structures and bioactive properties. This review aims to survey natural products, originating from terrestrial plants and microorganisms, marine organisms, and marine-derived microorganisms, which could influence LXRs and FXR. In the recent two decades (2000–2020), 261 natural products were discovered from natural resources such as LXRs/FXR modulators, 109 agonists and 38 antagonists targeting LXRs, and 72 agonists and 55 antagonists targeting FXR. The docking evaluation of desired natural products targeted LXRs/FXR is finally discussed. This comprehensive overview will provide a reference for future study of novel LXRs and FXR agonists and antagonists to target human diseases, and attract an increasing number of professional scholars majoring in pharmacy and biology with more in-depth discussion. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8766425/ /pubmed/35069197 http://dx.doi.org/10.3389/fphar.2021.772435 Text en Copyright © 2022 She, Gu, Pang, Liu, Tang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
She, Jianglian
Gu, Tanwei
Pang, Xiaoyan
Liu, Yonghong
Tang, Lan
Zhou, Xuefeng
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title_full Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title_fullStr Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title_full_unstemmed Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title_short Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
title_sort natural products targeting liver x receptors or farnesoid x receptor
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766425/
https://www.ncbi.nlm.nih.gov/pubmed/35069197
http://dx.doi.org/10.3389/fphar.2021.772435
work_keys_str_mv AT shejianglian naturalproductstargetingliverxreceptorsorfarnesoidxreceptor
AT gutanwei naturalproductstargetingliverxreceptorsorfarnesoidxreceptor
AT pangxiaoyan naturalproductstargetingliverxreceptorsorfarnesoidxreceptor
AT liuyonghong naturalproductstargetingliverxreceptorsorfarnesoidxreceptor
AT tanglan naturalproductstargetingliverxreceptorsorfarnesoidxreceptor
AT zhouxuefeng naturalproductstargetingliverxreceptorsorfarnesoidxreceptor